Biomedical (basic)

Ended Definitive Contract Awarded Last action

Contract number
266030070
Awardee
Awarding agency
Obligated
$10,345,302

Award facts

Contract value 39% obligated
  • $16,408,286.33 Current, with exercised options
  • $26,480,605.33 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer
Pricing
Cost No Fee
Place of performance
Ruxton, MD 21204, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 10 -$1
Other Administrative Action 9 $0
Funding Only Action 8 · Additional funds and extend period of performance $110,000
Other Administrative Action 7 · Change of cotr. $0
Funding Only Action 6 $1,000,000
Funding Only Action 5 $1,847,016
Other Administrative Action 4 $0
Funding Only Action 3 $4,278,287
Funding Only Action 2 $3,110,000
Original award $0

Quick answers

Who was awarded contract 266030070?

266030070 was awarded to Primary Immunodeficiency Research Consortium Incorporated by NIAID DEA OA Acquisitions (National Institutes of Health) on June 30, 2004.

How much is contract 266030070 worth?

The government has obligated $10,345,302 on 266030070. Its current value, with exercised options, is $16,408,286. Its potential value, with all options, is $26,480,605.

Was contract 266030070 competed?

The extent of competition for 266030070 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login